Published in J Am Coll Cardiol on October 10, 2012
Appropriate use criteria to reduce underuse and overuse: striking the right balance. J Am Coll Cardiol (2012) 1.69
Patient and hospital characteristics associated with inappropriate percutaneous coronary interventions. J Am Coll Cardiol (2013) 1.55
Appropriate use criteria to reduce underuse and overuse of revascularization. J Am Coll Cardiol (2013) 1.39
Myocardial ischemia is a key factor in the management of stable coronary artery disease. World J Cardiol (2014) 0.78
The transition to value-based care. J Interv Card Electrophysiol (2016) 0.78
Adherence to process of care quality indicators after percutaneous coronary intervention in Ontario, Canada: a retrospective observational cohort study. Open Heart (2015) 0.77
Reply: To PMID 23062534. J Am Coll Cardiol (2013) 0.75
Effect of angina under-recognition on treatment in outpatients with stable ischaemic heart disease. Eur Heart J Qual Care Clin Outcomes (2016) 0.75
Association between appropriateness of coronary revascularization and quality of life in patients with stable ischemic heart disease. BMC Cardiovasc Disord (2014) 0.75
Percutaneous Coronary Intervention Utilization and Appropriateness across the United States. PLoS One (2015) 0.75
The China Patient-Centred Evaluative Assessment of Cardiac Events (China PEACE)-Prospective Study of 3-Vessel Disease: rationale and design. BMJ Open (2016) 0.75
Relation between initial treatment strategy in stable coronary artery disease and 1-year costs in Ontario: a population-based cohort study. CMAJ Open (2016) 0.75
Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. N Engl J Med (2006) 18.25
Mammographic density and the risk and detection of breast cancer. N Engl J Med (2007) 14.32
Outcome of heart failure with preserved ejection fraction in a population-based study. N Engl J Med (2006) 10.58
Randomized trial of primary PCI with or without routine manual thrombectomy. N Engl J Med (2015) 7.83
Relation between age and cardiovascular disease in men and women with diabetes compared with non-diabetic people: a population-based retrospective cohort study. Lancet (2006) 6.64
Predicting mortality among patients hospitalized for heart failure: derivation and validation of a clinical model. JAMA (2003) 6.39
Adherence with statin therapy in elderly patients with and without acute coronary syndromes. JAMA (2002) 6.30
A population-based study of the drug interaction between proton pump inhibitors and clopidogrel. CMAJ (2009) 6.21
Routine early angioplasty after fibrinolysis for acute myocardial infarction. N Engl J Med (2009) 6.18
Transcatheter aortic valve implantation for the treatment of severe symptomatic aortic stenosis in patients at very high or prohibitive surgical risk: acute and late outcomes of the multicenter Canadian experience. J Am Coll Cardiol (2010) 5.09
Early versus delayed invasive intervention in acute coronary syndromes. N Engl J Med (2009) 4.83
A multicenter study of the coding accuracy of hospital discharge administrative data for patients admitted to cardiac care units in Ontario. Am Heart J (2002) 4.65
Comparison of coding of heart failure and comorbidities in administrative and clinical data for use in outcomes research. Med Care (2005) 4.30
A randomized comparison of radial-artery and saphenous-vein coronary bypass grafts. N Engl J Med (2004) 4.07
Warfarin use and the risk for stroke and bleeding in patients with atrial fibrillation undergoing dialysis. Circulation (2014) 3.78
Relation of disease pathogenesis and risk factors to heart failure with preserved or reduced ejection fraction: insights from the framingham heart study of the national heart, lung, and blood institute. Circulation (2009) 3.55
Effect of socioeconomic status on treatment and mortality after stroke. Stroke (2002) 3.44
Potentially preventable strokes in high-risk patients with atrial fibrillation who are not adequately anticoagulated. Stroke (2008) 3.14
Prognosis and determinants of survival in patients newly hospitalized for heart failure: a population-based study. Arch Intern Med (2002) 3.09
Risk-treatment mismatch in the pharmacotherapy of heart failure. JAMA (2005) 3.05
Socioeconomic status and mortality after acute myocardial infarction. Ann Intern Med (2006) 3.02
Rhythm versus rate control therapy and subsequent stroke or transient ischemic attack in patients with atrial fibrillation. Circulation (2012) 2.96
Comparing hierarchical modeling with traditional logistic regression analysis among patients hospitalized with acute myocardial infarction: should we be analyzing cardiovascular outcomes data differently? Am Heart J (2003) 2.88
Deriving ethnic-specific BMI cutoff points for assessing diabetes risk. Diabetes Care (2011) 2.87
Impact of hospital nursing care on 30-day mortality for acute medical patients. J Adv Nurs (2007) 2.85
Use of fibrates in the United States and Canada. JAMA (2011) 2.82
The Canadian study of the sirolimus-eluting stent in the treatment of patients with long de novo lesions in small native coronary arteries (C-SIRIUS). J Am Coll Cardiol (2004) 2.78
Prevalence, predictors, and outcomes of primary nonadherence after acute myocardial infarction. Circulation (2008) 2.76
Automated variable selection methods for logistic regression produced unstable models for predicting acute myocardial infarction mortality. J Clin Epidemiol (2004) 2.69
Modeling the cardiac surgery workforce in Canada. Ann Thorac Surg (2010) 2.61
Association of temporal trends in risk factors and treatment uptake with coronary heart disease mortality, 1994-2005. JAMA (2010) 2.61
Care and outcomes of patients newly hospitalized for heart failure in the community treated by cardiologists compared with other specialists. Circulation (2003) 2.61
Cardiac Angiography in Renally Impaired Patients (CARE) study: a randomized double-blind trial of contrast-induced nephropathy in patients with chronic kidney disease. Circulation (2007) 2.59
Patients with prior myocardial infarction, stroke, or symptomatic peripheral arterial disease in the CHARISMA trial. J Am Coll Cardiol (2007) 2.56
Administrative Data Feedback for Effective Cardiac Treatment: AFFECT, a cluster randomized trial. JAMA (2005) 2.54
Effectiveness and safety of drug-eluting stents in Ontario. N Engl J Med (2007) 2.50
Body size, mammographic density, and breast cancer risk. Cancer Epidemiol Biomarkers Prev (2006) 2.44
Safety and efficacy of drug-eluting and bare metal stents: comprehensive meta-analysis of randomized trials and observational studies. Circulation (2009) 2.40
Impact of patient and target-vessel characteristics on arterial and venous bypass graft patency: insight from a randomized trial. Circulation (2007) 2.39
Skeletonization of bilateral internal thoracic artery grafts lowers the risk of sternal infection in patients with diabetes. J Thorac Cardiovasc Surg (2003) 2.39
LARP7 is a stable component of the 7SK snRNP while P-TEFb, HEXIM1 and hnRNP A1 are reversibly associated. Nucleic Acids Res (2008) 2.38
A randomized comparison of intraoperative indocyanine green angiography and transit-time flow measurement to detect technical errors in coronary bypass grafts. J Thorac Cardiovasc Surg (2006) 2.35
Suppression of Tetherin-restricting activity upon human immunodeficiency virus type 1 particle release correlates with localization of Vpu in the trans-Golgi network. J Virol (2009) 2.35
The use of the propensity score for estimating treatment effects: administrative versus clinical data. Stat Med (2005) 2.31
Effects of contemporary troponin assay sensitivity on the utility of the early markers myoglobin and CKMB isoforms in evaluating patients with possible acute myocardial infarction. Clin Chim Acta (2007) 2.31
Improved outcomes with early collaborative care of ambulatory heart failure patients discharged from the emergency department. Circulation (2010) 2.29
IScore: a risk score to predict death early after hospitalization for an acute ischemic stroke. Circulation (2011) 2.29
Sex differences in carotid endarterectomy outcomes: results from the Ontario Carotid Endarterectomy Registry. Stroke (2003) 2.28
Comparison of provincial prescription drug plans and the impact on patients' annual drug expenditures. CMAJ (2008) 2.23
Contrast-induced nephropathy and long-term adverse events: cause and effect? Clin J Am Soc Nephrol (2009) 2.23
The potential economic impact of restricted access to angiotensin-receptor blockers. CMAJ (2011) 2.22
Carpentier-Edwards Perimount Magna valve versus Medtronic Hancock II: a matched hemodynamic comparison. Ann Thorac Surg (2007) 2.22
Vpr R77Q is associated with long-term nonprogressive HIV infection and impaired induction of apoptosis. J Clin Invest (2003) 2.21
Trends in risk factors for cardiovascular disease in Canada: temporal, socio-demographic and geographic factors. CMAJ (2009) 2.16
Effect of cardiac and noncardiac conditions on survival after defibrillator implantation. J Am Coll Cardiol (2007) 2.15
HIV-1 Vpr-mediated G2 arrest involves the DDB1-CUL4AVPRBP E3 ubiquitin ligase. PLoS Pathog (2007) 2.13
Antagonism of tetherin restriction of HIV-1 release by Vpu involves binding and sequestration of the restriction factor in a perinuclear compartment. PLoS Pathog (2010) 2.12
Bundle branch block patterns and long-term outcomes in heart failure. Int J Cardiol (2010) 2.07
Aspirin use and outcomes in a community-based cohort of 7352 patients discharged after first hospitalization for heart failure. Circulation (2006) 2.05
Cardiovascular complications and mortality after diabetes diagnosis for South Asian and Chinese patients: a population-based cohort study. Diabetes Care (2013) 2.04
Prevalence and extent of obstructive coronary artery disease among patients undergoing elective coronary catheterization in New York State and Ontario. JAMA (2013) 2.03
Use of niacin in the United States and Canada. JAMA Intern Med (2013) 2.02
Long-term trends in use of and expenditures for cardiovascular medications in Canada. CMAJ (2009) 2.02
Ontario multidetector computed tomographic coronary angiography study: field evaluation of diagnostic accuracy. Arch Intern Med (2011) 1.97
The striking effect of the Heart Outcomes Prevention Evaluation (HOPE) on ramipril prescribing in Ontario. CMAJ (2003) 1.94
Life expectancy after an index hospitalization for patients with heart failure: a population-based study. Am Heart J (2008) 1.92
Lifetime analysis of hospitalizations and survival of patients newly admitted with heart failure. Circ Heart Fail (2012) 1.92
Comparison of cardiovascular risk profiles among ethnic groups using population health surveys between 1996 and 2007. CMAJ (2010) 1.85
Use of ezetimibe in the United States and Canada. N Engl J Med (2008) 1.85
Early deaths in patients with heart failure discharged from the emergency department: a population-based analysis. Circ Heart Fail (2010) 1.83
Temporal trends in the use of percutaneous coronary intervention and coronary artery bypass surgery in New York State and Ontario. Circulation (2010) 1.82
Sex differences in implantable cardioverter-defibrillator outcomes: findings from a prospective defibrillator database. Ann Intern Med (2012) 1.80
Regional differences in process of care and outcomes for older acute myocardial infarction patients in the United States and Ontario, Canada. Circulation (2006) 1.78
Radial artery access as a predictor of increased radiation exposure during a diagnostic cardiac catheterization procedure. JACC Cardiovasc Interv (2011) 1.78
Diuretic dose and long-term outcomes in elderly patients with heart failure after hospitalization. Am Heart J (2010) 1.76
Geography and service supply do not explain socioeconomic gradients in angiography use after acute myocardial infarction. CMAJ (2003) 1.76
Impact of the choice of benchmark on the conclusions of hospital report cards. Am Heart J (2004) 1.72
Hospitalization rates and length of stay for cardiovascular conditions in Canada, 1994 to 1999. Can J Cardiol (2003) 1.71
Clinical outcomes after separate and composite replacement of the aortic valve and ascending aorta. J Thorac Cardiovasc Surg (2004) 1.71
Emergency department triage of acute myocardial infarction patients and the effect on outcomes. Ann Emerg Med (2009) 1.71
Inpatient smoking-cessation counseling and all-cause mortality in patients with acute myocardial infarction. Am Heart J (2007) 1.69
The identification and development of Canadian coronary artery bypass graft surgery quality indicators. J Thorac Cardiovasc Surg (2005) 1.68
Risk of elective major noncardiac surgery after coronary stent insertion: a population-based study. Circulation (2012) 1.67
The effect of a charted history of depression on emergency department triage and outcomes in patients with acute myocardial infarction. CMAJ (2011) 1.66
Productive human immunodeficiency virus type 1 assembly takes place at the plasma membrane. J Virol (2007) 1.66
Formation of mobile chromatin-associated nuclear foci containing HIV-1 Vpr and VPRBP is critical for the induction of G2 cell cycle arrest. PLoS Pathog (2010) 1.65
Population rates of cardiac catheterization and yield of high-risk coronary artery disease. CMAJ (2005) 1.64
Meta-analysis of the effects of endothelin receptor blockade on survival in experimental heart failure. J Card Fail (2003) 1.64
HIV-1 Vpr causes neuronal apoptosis and in vivo neurodegeneration. J Neurosci (2007) 1.64